Geneyork Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GENEYORK PHARMS
GENEYORK PHARMS has five approved drugs.
Summary for Geneyork Pharms
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Geneyork Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geneyork Pharms | DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 214890-001 | Jul 7, 2023 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Geneyork Pharms | PREDNISONE | prednisone | TABLET;ORAL | 211496-001 | Dec 28, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Geneyork Pharms | PREDNISONE | prednisone | TABLET;ORAL | 210525-004 | Dec 7, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
